| NCT ID | NCT06296485 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kaiser Permanente |
| Condition | Diabetes Mellitus, Type 2 |
| Study Type | INTERVENTIONAL |
| Enrollment | 360 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2027-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 360 participants in total. It began in 2024-05-01 with a primary completion date of 2027-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.
Eligibility Criteria
Inclusion Criteria: * Age 75 years and older * Diagnosis of Type 2 Diabetes * Current treatment with insulin * Increased hypoglycemia risk (prior year hypoglycemia by self-report or utilization) * Able to communicate in English * Able to access email and the Internet Exclusion Criteria: * On renal dialysis * Dementia * Pacemaker or Automatic Implantable Cardioverter Defibrillator * Using insulin pump * Severe Mental Illness * Severe Visual Impairment * In Hospice * Current or recent CGM use
Contact & Investigator
Richard W Grant, MD MPH
PRINCIPAL INVESTIGATOR
Kaiser Permanente Northern California - Division of Research
Frequently Asked Questions
Who can join the NCT06296485 clinical trial?
This trial is open to participants of all sexes, aged 75 Years or older, studying Diabetes Mellitus, Type 2. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06296485 currently recruiting?
Yes, NCT06296485 is actively recruiting participants. Contact the research team at Susana.C.Gonzalez@kp.org for enrollment information.
Where is the NCT06296485 trial being conducted?
This trial is being conducted at Fremont, United States, San Jose, United States, San Leandro, United States, Union City, United States.
Who is sponsoring the NCT06296485 clinical trial?
NCT06296485 is sponsored by Kaiser Permanente. The principal investigator is Richard W Grant, MD MPH at Kaiser Permanente Northern California - Division of Research. The trial plans to enroll 360 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.